Product Details-
| Composition | Methylprednisolone 4mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10×10 |
| Packing | Alu-Alu |
MYLPRE 4 is a high-quality pharmaceutical formulation containing Methylprednisolone 4mg as its active ingredient. It belongs to the class of corticosteroids, widely used for their anti-inflammatory, immunosuppressive, and anti-allergic properties. This medication plays a critical role in managing a broad spectrum of medical conditions, ranging from allergic reactions and respiratory disorders to autoimmune diseases and chronic inflammatory conditions. MYLPRE 4 is designed for oral administration, offering precise dosing, rapid absorption, and reliable results.
The 4mg strength is ideal for initiating treatment, tapering doses, or managing mild to moderate inflammatory conditions. It is formulated under strict quality control standards to ensure purity, efficacy, and patient safety.
Active Ingredient: Methylprednisolone 4mg
Pharmacological Class: Synthetic corticosteroid (glucocorticoid)
Methylprednisolone works by modulating the immune system response and reducing inflammation. It mimics the action of cortisol, a natural hormone produced by the adrenal glands. Its mechanism includes:
Suppressing inflammatory mediators like prostaglandins and leukotrienes.
Inhibiting immune responses by reducing the activity of T-cells and cytokine release.
Preventing fluid accumulation at sites of inflammation.
Providing symptomatic relief from redness, swelling, pain, and allergic reactions.
This makes MYLPRE 4 a versatile and effective choice for clinicians across multiple specialties.
Accurate and Consistent Dosage: Each tablet delivers a precise 4mg of Methylprednisolone.
Rapid Absorption: Ensures faster onset of action.
Quality Manufacturing: Produced under GMP-certified facilities.
Versatile Application: Suitable for treating diverse inflammatory and autoimmune disorders.
Convenient Dose Titration: 4mg strength is ideal for adjusting doses in chronic conditions or during corticosteroid tapering schedules.
MYLPRE 4 is prescribed for multiple health conditions where inflammation or immune system dysregulation is a primary concern. Common indications include:
Allergic Conditions:
Severe allergic rhinitis
Atopic dermatitis
Drug reactions
Urticaria and insect bites
Respiratory Disorders:
Bronchial asthma
Chronic obstructive pulmonary disease (COPD) exacerbations
Hypersensitivity pneumonitis
Autoimmune Diseases:
Systemic lupus erythematosus (SLE)
Rheumatoid arthritis
Psoriatic arthritis
Ankylosing spondylitis
Dermatological Conditions:
Psoriasis
Severe eczema
Contact dermatitis
Endocrine Disorders:
Adrenal insufficiency (as replacement therapy)
Gastrointestinal Conditions:
Ulcerative colitis flare-ups
Crohn’s disease exacerbations
Oncology and Hematology:
Adjunct therapy in certain cancers
Management of hematological disorders like hemolytic anemia and thrombocytopenia
Other Applications:
Nephrotic syndrome
Multiple sclerosis relapses
Organ transplantation (to prevent rejection)
Typical Adult Dose: Varies based on the condition and severity. Initial doses may range from 4mg to 48mg per day.
Tapering Strategy: Methylprednisolone should never be discontinued abruptly after prolonged use; tapering is necessary to avoid adrenal insufficiency.
Route of Administration: Oral, with or without food.
Pediatric Use: Dose adjustment is required based on body weight and clinical response.
Elderly Patients: Dose adjustments may be necessary for age-related organ function decline.
Important: Dosage should always be determined by a qualified healthcare provider.
Provides quick and effective relief from inflammation.
Helps control autoimmune diseases and prevents disease progression.
Reduces hospital visits by offering a convenient oral dosage.
Manufactured to ensure consistent bioavailability and safety.
Effective at low doses, minimizing potential side effects.
Absorption: Rapidly absorbed from the gastrointestinal tract.
Bioavailability: High systemic bioavailability ensures predictable results.
Half-life: Approximately 18-36 hours, providing sustained activity.
Metabolism: Primarily metabolized in the liver.
Excretion: Eliminated mainly through the kidneys.
While MYLPRE 4 is generally well-tolerated when taken under medical supervision, some patients may experience side effects, particularly with prolonged use or high doses. Common side effects include:
Gastrointestinal discomfort (nausea, vomiting, indigestion)
Headache and dizziness
Fluid retention and swelling
Weight gain
Mood changes or irritability
Insomnia
Increased susceptibility to infections
Long-term use may cause osteoporosis, hypertension, or adrenal suppression
Infection Risk: Corticosteroids suppress immunity, increasing the risk of infections. Avoid exposure to contagious diseases.
Pregnancy and Lactation: Use only if benefits outweigh risks; consult a doctor.
Diabetes: Can elevate blood sugar levels; monitor closely.
Hypertension and Heart Conditions: May worsen fluid retention.
Gastrointestinal Disorders: Use with caution in patients with peptic ulcer disease.
Vaccinations: Live vaccines should be avoided during corticosteroid therapy.
Abrupt Discontinuation: Can cause adrenal insufficiency; follow tapering instructions.
Methylprednisolone may interact with:
NSAIDs: Increased risk of gastrointestinal bleeding.
Diabetic Medications: May reduce their efficacy.
Anticoagulants: Can alter blood clotting parameters.
Live Vaccines: Reduced vaccine efficacy and increased risk of infection.
Other Steroids: Risk of additive effects.
Store in a cool, dry place, away from direct sunlight.
Keep out of reach of children.
Do not use beyond the expiry date mentioned on the pack.
MYLPRE 4 tablets are typically packed in blister packs, ensuring product integrity, moisture protection, and ease of use.
Trusted Efficacy: Formulated with clinically proven Methylprednisolone.
Patient-Friendly Dose: 4mg strength provides flexibility in dose adjustment.
Premium Quality: Manufactured under stringent quality assurance protocols.
Cost-Effective: Offers high therapeutic value at an affordable cost.
Versatile Applications: Useful across multiple medical specialties.
MYLPRE 4 is a reliable and effective corticosteroid medication designed to manage inflammation, allergic reactions, autoimmune conditions, and various chronic illnesses. With precise dosing, consistent bioavailability, and comprehensive quality checks, it is a trusted choice for both healthcare professionals and patients.
This formulation offers flexibility in therapy, especially for those requiring low-dose corticosteroid treatment or tapering regimens. When used responsibly under medical supervision, MYLPRE 4 plays an essential role in improving patient outcomes, reducing disease complications, and enhancing quality of life.
